STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2253 by analyst upside · 2026-08-14
ENSG
The Ensign Group, Inc.
Healthcare · Market Cap $11B · P/E 28.5x
ANALYST PRICE TARGET
+21.0%
implied upside to consensus target
Current Price $181.88
Consensus Target $220.0
Bull Target $230.0
Bear Target $207.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
1
Sell
0
52-Week Low $141.58
52-Week High $218.0
YTD Return +4.7%
FUNDAMENTALS
Market Cap $11B
P/E Ratio (TTM) 28.5x
Forward P/E 21.3x
EPS (TTM) $6.38
PEG Ratio 1.59
Dividend Yield 14.00%
Revenue (TTM) $5.5B
Profit Margin 6.9%
52-WEEK RANGE
52-Week Low $141.58
52-Week High $218.0
Current Price $181.88
Bear Target $207.0
Bull Target $230.0
● Now $181.88 ● Target $220.0
TRADING DATA
Avg Volume 787K
YTD Return +4.7%
Analyst Count 5
Consensus Buy
Upside to Target +21.0%
Last Updated 2026-08-14

ANALYST SUMMARY

The Ensign Group, Inc. (ENSG) is currently trading at $181.88 with a Wall Street consensus price target of $220.0, implying potential upside of 21.0% over the next 12 months. 5 analysts currently cover ENSG, with a consensus rating of Buy - 80% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $230.0, while the most cautious has a target of $207.0.

ENSG operates in the Healthcare sector with a market capitalisation of $11B. The stock is up 4.7% year-to-date and is currently trading near the upper end of its 52-week range of $141.58 – $218.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ENSG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital - Reiterated
Outperform → Outperform 2026-02-09 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-02-06 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2025-11-14 Building track record
Truist Securities - Reiterated
Hold → Hold 2025-11-10 Building track record
UBS - Reiterated
Buy → Buy 2025-11-05 33% win rate (6 calls)
Stephens & Co. - Reiterated
Overweight → Overweight 2025-11-05 Building track record
UBS - Reiterated
Buy → Buy 2025-09-02 33% win rate (6 calls)
UBS - Reiterated
Buy → Buy 2025-08-14 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
63
out of 100
Coverage depth
14/30
Consensus clarity
27/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →